Skip to main content
AAN.com

Abstract

Objective: To define the spectrum of clinical and biochemical features in 51 children with isolated complex I deficiency.
Background: Mitochondrial respiratory chain defects are one of the most commonly diagnosed inborn errors of metabolism. Until recently there have been technical problems with the diagnosis of respiratory chain complex I defects, and there is a lack of information about this underreported cause of respiratory chain dysfunction.
Methods: A retrospective review of clinical features and laboratory findings was undertaken in all diagnosed patients who had samples referred over a 22-year period.
Results: Presentations were heterogeneous, ranging from severe multisystem disease with neonatal death to isolated myopathy. Classic indicators of respiratory chain disease were not present in 16 of 42 patients in whom blood lactate levels were normal on at least one occasion, and in 23 of 37 patients in whom muscle morphology was normal or nonspecific. Ragged red fibers were present in only five patients. Tissue specificity was observed in 19 of 41 patients in whom multiple tissues were examined, thus the diagnosis may be missed if the affected tissue is not analyzed. Nine patients had only skin fibroblasts available, the diagnosis being based on enzyme assay and functional tests. Modes of inheritance include autosomal recessive (suggested in five consanguineous families), maternal (mitochondrial DNA point mutations in eight patients), and possibly X-linked (slight male predominance of 30:21). Recurrence risk was estimated as 20 to 25%.
Conclusion: Heterogeneous clinical features, tissue specificity, and absence of lactic acidosis or abnormal mitochondrial morphology in many patients have resulted in underdiagnosis of respiratory chain complex I deficiency.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Smeitink JAM, Loeffen JLCM, Triepels RH, Smeets RJP, Trijbels JMF, van den Heuvel LP. Nuclear genes of human complex I of the mitochondrial electron transport chain : state of the art. Hum Mol Genet 1998;7:1573–1579.
2.
Morgan–Hughes JA, Darveniza P, Landon DN, Land JM, Clark JB. A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity. J Neurol Sci 1979;43:27–46.
3.
Birch–Machin MA, Briggs HL, Saborido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complexes I–IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol 1994;51:35–42.
4.
Cooper JM, Mann VM, Krige D, Schapira AHV. Human mitochondrial complex-I dysfunction. Biochim Biophys Acta 1992;1101:198–203.
5.
Robinson BH. Lacticacidemia. Biochim Biophys Acta 1993;1182:231–244.
6.
Pitkanen S, Feigenbaum A, Laframboise R, Robinson BH. NADH-coenzyme Q reductase (complex I) deficiency : heterogeneity in phenotype and biochemical findings. J Inher Metab Dis 1996;19:675–686.
7.
Rahman S, Blok RB, Dahl HHM, et al. Leigh syndrome : clinical features and biochemical and DNA abnormalities. Ann Neurol 1996;39:343–351.
8.
Morris AAM, Leonard JV, Brown GK, et al. Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol 1996;40:25–30.
9.
Koga Y, Nonaka I, Kobayashi M, Tojyo M, Nihei K. Findings in muscle in complex I (NADH coenzyme Q reductase) deficiency. Ann Neurol 1988;24:749–756.
10.
Schapira AHV. Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta 1998;1364:261–270.
11.
Tulinius MH, Holme E, Kristiansson B, Larsson NG, Oldfors A. Mitochondrial encephalomyopathies in childhood. 1. Biochemical and morphologic investigations. J Pediatr 1991;119:242–250.
12.
Parker WDJ, Boyson SJ, Luder AS, Parks JK. Evidence for a defect in NADH : ubiquinone oxidoreductase (complex I) in Huntington’s disease. Neurology 1990;40:1231–1234.
13.
Ellaway C, North K, Arbuckle S, Christodoulou J. Complex I deficiency in association with structural abnormalities of the diaphragm and brain. J Inher Metab Dis 1998;21:72–73.
14.
Ogle RF, Christodoulou J, Fagan E, et al. Mitochondrial myopathy with tRNALeu(UUR) mutation and complex I deficiency responsive to riboflavin. J Pediatr 1997;130:138–145.
15.
McKusick VA. Human genetics. Englewood Cliffs, NJ:Prentice-Hall, 1969:125–159.
16.
Wanders RJA, Ruiter JPN, Wijburg FA. Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts : application to mitochondrial encephalomyopathies. Biochim Biophys Acta 1993;1181:219–222.
17.
Robinson BH, Petrova–Benedict R, Buncic JR, Wallace DC. Nonviability of cells with oxidative defects in galactose medium : a screening test for affected patient fibroblasts. Biochem Med Metab Biol 1992;48:122–126.
18.
Howell N, Kubacka I, Xu M, McCullough DA. Leber hereditary optic neuropathy : involvement of the mitochondrial NDI gene and evidence for an intragenic suppressor mutation. Am J Hum Genet 1991;48:935–942.
19.
Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1991;48:1147–1153.
20.
Johns DR, Neufeld MJ. Pitfalls in the molecular genetic diagnosis of Leber hereditary optic neuropathy (LHON). Am J Hum Genet 1993;53:916–920.
21.
Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994;91:6206–6210.
22.
Lowerson SA, Taylor L, Briggs HL, Turnbull DM. Measurement of the activity of individual respiratory chain complexes in isolated fibroblast mitochondria. Anal Biochem 1992;205:372–374.
23.
Shoffner JM, Brown MD, Stugard C, et al. Leber’s hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995;38:163–169.
24.
Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991;1097:238–240.
25.
Silvestri G, Santorelli FM, Shanske S, et al. A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994;3:37–43.
26.
Bernsen PLJA, Gabreels FJM, Ruitenbeek W, Sengers RCA, Stadhouders AM, Renier WO. Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine. Arch Neurol 1991;48:334–338.
27.
Pitkanen S, Raha S, Robinson BH. Diagnosis of complex I deficiency in patients with lactic acidemia using skin fibroblast cultures. Biochem Mol Med 1996;59:134–137.
28.
Chretien D, Rustin P, Bourgeron T, Rotig A, Saudubray JM, Munnich A. Reference charts for respiratory chain activities in human tissues. Clin Chim Acta 1994;228:53–70.
29.
Pitkanen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 1996;98:345–351.
30.
Davey GP, Peuchen S, Clark JB. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J Biol Chem 1998;273:12753–12757.
31.
Clay VJ, Ragan CI. Evidence for the existence of tissue specific isoenzymes of mitochondrial NADH dehydrogenase. Biochem Biophys Res Commun 1988;157:1423–1428.
32.
Dunbar DR, Moonie PA, Zeviani M, Holt IJ. Complex I deficiency is associated with 3243G :C mitochondrial DNA in osteosarcoma cell cybrids. Hum Mol Genet 1996;5:123–129.
33.
Bindoff LA, Howell N, Poulton J, et al. Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA—a potential disease mechanism. J Biol Chem 1993;268:19559–19564.
34.
Parfait B, Percheron A, Chretien D, Rustin P, Munnich A, Rotig A. No mitochondrial cytochrome oxidase (COX) gene mutations in 18 cases of COX deficiency. Hum Genet 1997;101:247–250.
35.
Day CE, Scheffler IE. Mapping of the genes of some components of the electron transport chain (complex I) on the X chromosome of mammals. Somat Cell Genet 1982;8:691–707.
36.
Kaufmann P, Koga Y, Shanske S, et al. Mitochondrial DNA and RNA processing in MELAS. Ann Neurol 1996;40:172–180.

Information & Authors

Information

Published In

Neurology®
Volume 52Number 6April 1, 1999
Pages: 1255
PubMed: 10214753

Publication History

Received: August 26, 1998
Accepted: December 24, 1998
Published online: April 1, 1999
Published in print: April 1, 1999

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

D.M. Kirby, BSc(Hons)
From the Murdoch Institute (Drs. KirbyCrawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.
M. Crawford, Dip.MLT
From the Murdoch Institute (Drs. KirbyCrawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.
M.A. Cleary, MBChB (UK)
From the Murdoch Institute (Drs. KirbyCrawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.
H.-H.M. Dahl, PhD
From the Murdoch Institute (Drs. KirbyCrawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.
X. Dennett, PhD
From the Murdoch Institute (Drs. KirbyCrawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.
D.R. Thorburn, PhD
From the Murdoch Institute (Drs. KirbyCrawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.

Notes

Address correspondence and reprint requests to Dr. David Thorburn, The Murdoch Institute, Royal Children’s Hospital, Flemington Road, Parkville, VIC 3052, Australia.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Degenerative Disorders of the Newborn, Volpe's Neurology of the Newborn, (967-1007.e17), (2025).https://doi.org/10.1016/B978-0-443-10513-5.00033-4
    Crossref
  2. A Homozygous NDUFS6 Variant Associated with Neuropathy and Optic Atrophy, Journal of Neuromuscular Diseases, 11, 2, (485-491), (2024).https://doi.org/10.3233/JND-230181
    Crossref
  3. X-Linked Myotubular Myopathy and Mitochondrial Function in Muscle and Liver Samples, Neuropediatrics, (2024).https://doi.org/10.1055/s-0044-1788333
    Crossref
  4. Restoration of defective oxidative phosphorylation to a subset of neurons prevents mitochondrial encephalopathy, EMBO Molecular Medicine, 16, 9, (2210-2232), (2024).https://doi.org/10.1038/s44321-024-00111-4
    Crossref
  5. Systematic analysis of NDUFAF6 in complex I assembly and mitochondrial disease, Nature Metabolism, 6, 6, (1128-1142), (2024).https://doi.org/10.1038/s42255-024-01039-2
    Crossref
  6. Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders, Genetics in Medicine, 26, 6, (101117), (2024).https://doi.org/10.1016/j.gim.2024.101117
    Crossref
  7. Systems Biology Approach in Understanding Mitochondrial Disease, Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases, (173-193), (2024).https://doi.org/10.1007/978-981-99-9462-5_8
    Crossref
  8. Mitochondrial Complex I Deficiency, Nuclear Types 1–37 (MC1DN) and Mitochondrial Type 1 (MC1DM1), Genetic Syndromes, (1-5), (2024).https://doi.org/10.1007/978-3-319-66816-1_1363-1
    Crossref
  9. Unique prenatal manifestations of biallelic NDUFAF5 variants: expansion of phenotype , Ultrasound in Obstetrics & Gynecology, 63, 3, (392-398), (2024).https://doi.org/10.1002/uog.27482
    Crossref
  10. Acute Encephalopathy Caused by Inherited Metabolic Diseases, Journal of Clinical Medicine, 12, 11, (3797), (2023).https://doi.org/10.3390/jcm12113797
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share